GUY P NOHRA
CIK 1198330 · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$34.08M
Companies
11
Total Filings
40
Lifetime Open-Market Net
$45.83M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TELA | Director | 23,600 | $0.86 | $20.3K | $0 | 1 | 2026-06-11 |
| BVS | Director | 148,892 | $8.51 | $1.27M | -$75.7K | 13 | 2026-06-04 |
| Allakos Inc. (ALLK) Delisted | 10%+ Owner | 6,467,510 | $0.33 | $2.13M | -$3.46M | 2 | 2021-03-08 |
| ZS Pharma, Inc. (ZSPH) Delisted | Director | — | — | — | $0 | 2 | 2015-06-25 |
| LIFE | 10%+ Owner | 1,685,758 | $15.61 | $26.31M | $0 | 1 | 2015-05-14 |
| Evofem Biosciences, Inc. (NEOT) Delisted | 10%+ Owner | 2,597,024 | — | — | -$5.55M | 1 | 2014-11-25 |
| TRVN | 10%+ Owner | 967,741 | $0.01 | $10.7K | $16.53M | 1 | 2014-02-07 |
| AERIE PHARMACEUTICALS INC (AERI) Delisted | 10%+ Owner | 200,000 | $15.25 | $3.05M | $4.40M | 1 | 2013-11-01 |
| TALPHERA, INC. (ACRX) Delisted | Director | 3,615,461 | $0.86 | $3.11M | $20.78M | 6 | 2013-09-23 |
| ESPR | 10%+ Owner | 2,052,189 | $3.15 | $6.46M | $13.20M | 1 | 2013-07-01 |
| COTHERIX INC (CTRX) Delisted | 0 | — | — | $0 | 1 | 2007-01-09 |
Recent Filings · Page 3 of 4
40 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-11-25 | Evofem Biosciences, Inc. (NEOT) Delisted | Mixed | +13,315,450 | $6.19M | EDGAR |
| 2014-08-26 | ZS Pharma, Inc. (ZSPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-02-07 | TRVN | Mixed | +19,451,310 | $16.53M | EDGAR |
| 2013-11-01 | AERIE PHARMACEUTICALS INC (AERI) Delisted | Mixed | +15,664,396 | $4.40M | EDGAR |
| 2013-09-23 | TALPHERA, INC. (ACRX) Delisted | Sell (S) | −158,153 | -$1.68M | EDGAR |
| 2013-09-18 | TALPHERA, INC. (ACRX) Delisted | Sell (S) | −128,780 | -$1.34M | EDGAR |
| 2013-09-16 | TALPHERA, INC. (ACRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-07-01 | ESPR | Mixed | +8,208,756 | $13.20M | EDGAR |
| 2012-07-26 | TALPHERA, INC. (ACRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-02-18 | TALPHERA, INC. (ACRX) Delisted | Mixed | +16,769,442 | $20.40M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.